The pathogenesis of clinical depression: Stressor- and cytokine-induced alterations of neuroplasticity

Neuroscience

Volumn 135, Issue 3, 2005, Pages 659-678

  Hayley, S ^a   Poulter, M O ^a   Merali, Z ^b   Anisman, H ^a,b  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

5 HT; BDNF; CRH; Inflammatory; Interleukin; Neurogenesis

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA INTERFERON; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DEXAMETHASONE; FLUOXETINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; NEUROTROPHIN; PAROXETINE; PROTEIN BCL 2; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA;

ANOREXIA; ANXIETY; APOPTOSIS; ATROPHY; CELL SURVIVAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEPRESSION; EXCITOTOXICITY; FATIGUE; HIPPOCAMPUS; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PAIN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; STRESS;

ANIMALS; CYTOKINES; DEPRESSION; HUMANS; NERVE GROWTH FACTORS; NEURONAL PLASTICITY; STRESS, PSYCHOLOGICAL;

EID: 26044443198     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.03.051     Document Type: Review

References (266)

1. G. Aguilera, C. Rabadan-Diehl, M. Nikodemova Regulation of pituitary corticotropin releasing hormone receptors Peptides 22 2001 769 774
2. S.M. Allan, N.J. Rothwell Cytokines and acute neurodegeneration Nat Rev Neurosci 2 2001 734 744
3. S.M. Allan Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system J Neurosci Res 67 2002 428 434
4. R. Alonso, G. Griebel, G. Pavone, J. Stemmelin, G. Le Fur, P. Soubrie Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression Mol Psychiatry 9 2004 278 286
5. C.A. Altar Neurotrophins and depression. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression Trends Pharmacol Sci 20 1999 59 61
6. T. Ando, A.J. Dunn Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice Neuroimmunomodulation 6 1999 319 329
7. M. Anguelova, C. Benkelfat, G. Turecki A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders Mol Psychiatry 8 2003 574 591
8. M. Anguelova, C. Benkelfat, G. Turecki A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior Mol Psychiatry 8 2003 646 653
9. H. Anisman, K. Matheson Anhedonia and depression caveats concerning animal models Neurosci Biobehav Rev 29 2005 1525 1546
10. H. Anisman, Z. Merali, S. Hayley Sensitization associated with stressors and cytokine treatments Brain Behav Immun 17 2003 86 93
11. H. Anisman, Z. Merali Anhedonic and anxiogenic effects of cytokine exposure Adv Exp Med Biol 461 1999 199 233
12. H. Anisman, A.V. Ravindran, J. Griffiths, Z. Merali Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features Mol Psychiatry 4 1999 182 188
13. V. Arango, M.D. Underwood, A.V. Gubbi, J.J. Mann Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims Brain Res 688 1995 121 133
14. M. Arato, C.M. Banki, G. Bissette, C.B. Nemeroff Elevated CSF CRF in suicide victims Biol Psychiatry 25 1989 355 359
15. L. Arborelius, M.J. Owens, P.M. Plotsky, C.B. Nemeroff The role of corticotropin-releasing factor in depression and anxiety disorders J Endocrinol 160 1999 1 12
16. S. Asbach, C. Schulz, H. Lehnert Effects of corticotropin-releasing hormone on locus coeruleus neurons in vivo a microdialysis study using a novel bilateral approach Eur J Endocrinol 145 2001 359 363
17. M.C. Austin, J.E. Janosky, H.A. Murphy Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men Mol Psychiatry 8 2003 324 332
18. C.M. Banki, L. Karmacsi, G. Bissette, C.B. Nemeroff CSF corticotropin-releasing hormone and somatostatin in major depression response to antidepressant treatment and relapse Eur Neuropsychopharmacol 2 1992 107 113
19. W.A. Banks, M.L. Niehoff, S.S. Zalcman Permeability of the mouse blood-brain barrier to murine interleukin-2 predominance of a saturable efflux system Brain Behav Immun 18 2004 434 442
20. R.M. Barrientos, D.B. Sprunger, S. Campeau, L.R. Watkins, J.W. Rudy, S.F. Maier BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration J Neuroimmunol 155 2004 119 126
21. R.M. Barrientos, D.B. Sprunger, S. Campeau, E.A. Higgins, L.R. Watkins, J.W. Rudy, S.F. Maier Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist Neuroscience 121 2003 847 853
22. A. Bayas, N. Kruse, N.F. Moriabadi, F. Weber, V. Hummel, G. Wohleben, R. Gold, K.V. Toyka, P. Rieckmann Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells Neurosci Lett 335 2003 155 158
23. G. Bissette, V. Klimek, J. Pan, C. Stockmeier, G. Ordway Elevated concentrations of CRF in the locus coeruleus of depressed subjects Neuropsychopharmacology 28 2003 1328 1335
24. P. Blier The pharmacology of putative early-onset antidepressant strategies Eur Neuropsychopharmacol 13 2003 57 66
25. L. Boisse, A. Mouihate, S. Ellis, Q.J. Pittman Long-term alterations in neuroimmune responses after neonatal exposure to lipopolysaccharide J Neurosci 24 2004 4928 4934
26. S. Bonaccorso, V. Marino, M. Biondi, F. Grimaldi, F. Ippolit, M. Maes Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus J Affect Disord 72 2002 237 241
27. S. Bonaccorso, V. Marino, A. Puzella, M. Pasquini, M. Biondi, M. Artini, C. Almerighi, R. Verkerk, H. Meltzer, M. Maes Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system J Clin Psychopharmacol 22 2002 86 90
28. T. Borowski, L. Kokkinidis, Z. Merali, H. Anisman Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia Neuroreport 9 1998 3797 3802
29. L.S. Brady Stress, antidepressant drugs, and the locus coeruleus Brain Res Bull 35 1994 545 556
30. K.T. Brady, T.K. Killeen, T. Brewerton, S. Lucerini Comorbidity of psychiatric disorders and posttraumatic stress disorder J Clin Psychiatry 7 2000 22 32
31. P. Brambilla, J. Perez, F. Barale, G. Schettini, J.C. Soares GABAergic dysfunction in mood disorders Mol Psychiatry 715 2003 721 737
32. K. Brebner, S. Hayley, Z. Merali, H. Anisman Synergistic effects of interleukin-1, interleukin-6, and TNF-α neuroendocrine, neurochemical and behavioral changes Neuropsychopharmacology 22 2000 566 580
33. S. Brecht, S. Simler, M. Vergnes, K. Mielke, C. Marescaux, T. Herdegen Repetitive electroconvulsive seizures induce activity of c-Jun N-terminal kinase and compartment-specific desensitization of c-Jun phosphorylation in the rat brain Mol Brain Res 68 1999 101 108
34. J.D. Bremner, M. Narayan, E.R. Anderson, L.H. Staib, H.L. Miller, D.S. Charney Hippocampal volume reduction in major depression Am J Psychiatry 157 2000 115 118
35. A.R. Brooks-Kayal, M.D. Shumate, H. Jin, D.D. Lin, T.Y. Rikhter, K.L. Holloway, D.A. Coulter Human neuronal gamma-aminobutyric acid(A) receptors coordinated subunit mRNA expression and functional correlates in individual dentate granule cells J Neurosci 19 1999 8312 8318
36. K. Buller, Y. Xu, C. Dayas, T. Day Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1beta-induced hypothalamic pituitary adrenal axis responses Neuroendocrinology 73 2001 129 138
37. S. Campbell, M. Marriott, C. Nahmias, G.M. MacQueen Lower hippocampal volume in patients suffering from depression a meta-analysis Am J Psychiatry 61 2004 598 607
38. L. Capuron, A. Ravaud, A.H. Miller, R. Dantzer Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy Brain Behav Immun 18 2004 205 213
39. L. Capuron, C.L. Raison, D.L. Musselman, D.H. Lawson, C.B. Nemeroff, A.H. Miller Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am J Psychiatry 160 2003 1342 1345
40. L. Capuron, J.F. Gumnick, D.L. Musselman, D.H. Lawson, A. Reemsnyder, C.B. Nemeroff, A.H. Miller Neurobehavioral effects of interferon-alpha in cancer patients phenomenology and paroxetine responsiveness of symptom dimensions Neuropsychopharmacology 26 2002 643 652
41. L. Capuron, A. Ravaud, R. Dantzer Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy J Clin Oncol 18 2000 2143 2151
42. A. Caspi, K. Sugden, T.E. Moffitt, A. Taylor, I.W. Craig, H. Harrington, J. McClay, J. Mill, J. Martin, A. Braithwaite, R. Poulton Influence of life stress on depression moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389
43. S.C. Cheetham, M.R. Crompton, C.L. Katona, S.J. Parker, R.W. Horton Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims Brain Res 460 1988 114 123
44. C.J. Cook Measuring of extracellular cortisol and corticotropin-releasing hormone in the amygdala using immunosensor coupled microdialysis J Neurosci Methods 110 2001 95 101
45. S.C. Cook, C.L. Wellman Chronic stress alters dendritic morphology in rat medial prefrontal cortex J Neurobiol 60 2004 236 248
46. K.J. Cowan, K.B. Storey Mitogen-activated protein kinases new signaling pathways functioning in cellular responses to environmental stress Exp Biol 206 2003 1107 1115
47. J.T. Coyle, R.S. Duman Finding the intracellular signaling pathways affected by mood disorder treatments Neuron 38 2003 157 160
48. S.J. Crocker, W.R. Lamba, P.D. Smith, S.M. Callaghan, R.S. Slack, H. Anisman, D.S. Park c-Jun mediates axotomy-induced dopamine neuron death in vivo Proc Natl Acad Sci U S A 98 2001 13385 13390
49. J.A. Cross, S.C. Cheetham, M.R. Crompton, C.L. Katona, R.W. Horton Brain GABAB binding sites in depressed suicide victims Psychiatry Res 26 1988 119 129
50. W.E. Cullinan, T.J. Wolfe Chronic stress regulates levels of mRNA transcripts encoding beta subunits of the GABA(A) receptor in the rat stress axis Brain Res 887 2000 118 124
51. J. Curtis, S. Finkbeiner Sending signals from the synapse to the nucleus possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth Neurosci Res 58 1999 88 95
52. R. Dantzer Cytokine-induced sickness behavior Where do we stand? Brain Behav Immun 15 2001 7 24
53. F.M. Dautzenberg, R.L. Hauger The CRF peptide family and their receptors yet more partners discovered Trends Pharmacol Sci 23 2002 71 77
54. C.V. Dayas, K.M. Buller, J.W. Crane, Y. Xu, T.A. Day Stressor categorization acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups Eur J Neurosci 14 2001 1143 1152
55. C.V. Dayas, K.M. Buller, T.A. Day Neuroendocrine responses to an emotional stressor evidence for involvement of the medial but not the central amygdala Eur J Neurosci 11 1999 2312 2322
56. K.D. Denicoff, D.R. Rubinow, M.Z. Papa, L. Simpson, L.A. Seipp, M.T. Lotze, A.E. Chang, D. Rosenstein, S.A. Rosenberg The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells Ann Intern Med 107 1987 293 300
57. F.S. Dhabhar Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking Ann N Y Acad Sci 917 2000 876 893
58. E. Dieperink, S.B. Ho, P. Thuras, M.L. Willenbring A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C Psychosomatics 44 2003 104 112
59. E. Dieperink, M. Willenbring, S.B. Ho Neuropsychiatric symptoms associated with hepatitis C and interferon alpha A review Am J Psychiatry 157 2000 867 876
60. W.C. Drevets Neuroimaging and neuropathological studies of depression implications for the cognitive-emotional features of mood disorders Curr Opin Neurobiol 11 2001 240 249
61. C. D'Sa, R.S. Duman Antidepressants and neuroplasticity Bipolar Disord 4 2002 183 194
62. L. Du, G. Faludi, M. Palkovits, E. Demeter, D. Bakish, Y.D. Lapierre, P. Sotonyi, P.D. Hrdina Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims Biol Psychiatry 46 1999 196 201
63. R.S. Duman Role of neurotrophic factors in the etiology and treatment of mood disorders Neuromol Med 5 2004 11 25
64. R.S. Duman, J. Malberg, J. Thome Neural plasticity to stress and antidepressant treatment Biol Psychiatry 46 1999 1181 1191
65. Y. Dwivedi, H.S. Rizavi, P.K. Shukla, J. Lyons, G. Faludi, M. Palkovits, A. Sarosi, R.R. Conley, R.C. Roberts, C.A. Tamminga, G.N. Pandey Protein kinase A in postmortem brain of depressed suicide victims altered expression of specific regulatory and catalytic subunits Biol Psychiatry 55 2004 234 243
66. Y. Dwivedi, A.C. Mondal, P.K. Shukla, H.S. Rizavi, J. Lyons Altered protein kinase A in brain of learned helpless rats effects of acute and repeated stress Biol Psychiatry 56 2004 30 40
67. Y. Dwivedi, J.S. Rao, H.S. Rizavi, J. Kotowski, R.R. Conley, R.C. Roberts, C.A. Tamminga, G.N. Pandey Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects Arch Gen Psychiatry 60 2003 273 282
68. Y. Dwivedi, H.S. Rizavi, R.R. Conley, R.C. Roberts, C.A. Tamminga, G.N. Pandey Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects Arch Gen Psychiatry 60 2003 804 815
69. Y. Dwivedi, R.R. Conley, R.C. Roberts, C.A. Tamminga, G.N. Pandey [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims Am J Psychiatry 159 2002 66 73
70. Y. Dwivedi, H.S. Rizavi, R.C. Roberts, R.C. Conley, C.A. Tamminga, G.N. Pandey Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects J Neurochem 77 2001 916 928
71. D.S. Eom, W.S. Choi, Y.J. Oh Bcl-2 enhances neurite extension via activation of c-Jun N-terminal kinase Biochem Biophys Res Comm 314 2004 377 381
72. P.V. Escriba, A. Ozaita, J.A. Garcia-Sevilla Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims Neuropsychopharmacology 29 2004 1512 1521
73. J. Evenden Impulsivity a discussion of clinical and experimental findings J Psychopharmacol 13 1999 180 192
74. G. Faludi, L. Du, M. Palkovits, B. Antal, P. Sotonyi, P.D. Hrdina Serotonin transporter, serotonin-2A receptor and tryptophan hydroxilase gene polymorphisms in depressed suicide victims Neurobiology 8 2000 269 271
75. N. Frasure-Smith, F. Lesperance, G. Gravel, A. Masson, M. Juneau, M.G. Bourassa Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal heart attack readjustment trial Psychosom Med 64 2002 571 579
76. T. Frodl, E.M. Meisenzahl, P. Zill, T. Baghai, D. Rujescu, G. Leinsinger, R. Bottlender, C. Schule, P. Zwanzger, R.R. Engel, R. Rupprecht, B. Bondy, M. Reiser, H.J. Moller Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression Arch Gen Psychiatry 61 2004 177 183
77. H.M. Gao, B. Liu, W. Zhang, J.S. Hong Novel anti-inflammatory therapy for Parkinson's disease Trends Pharmacol Sci 24 2003 395 401
78. M.W. Gilbertson, M.E. Shenton, A. Ciszewski, K. Kasai, N.B. Lasko, S.P. Orr, R.K. Pitman Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma Nat Neurosci 5 2002 1242 1247
79. M.L. Gilmor, K.H. Skelton, C.B. Nemeroff, M.J. Owens The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems J Pharmacol Exp Ther 305 2003 434 439
80. L. Givalois, S. Arancibia, G. Alonso, L. Tapia-Arancibia Expression of brain-derived neurotrophic factor and its receptors in the median eminence cells with sensitivity to stress Endocrinology 145 2004 4737 4747
81. P.W. Gold, G.P. Chrousos Organization of the stress system and its dysregulation in melancholic and atypical depression high vs low CRH/NE states Mol Psychiatry 7 2002 254 275
82. E. Gould, B.S. McEwen Neuronal birth and death Curr Opin Neurobiol 3 1993 676 682
83. J. Griffiths, A.V. Ravindran, Z. Merali, H. Anisman Dysthymia Neurochemical and behavioral perspectives Mol Psychiatry 5 2000 242 261
84. A.J. Grippo, T.G. Beltz, A.K. Johnson Behavioral and cardiovascular changes in the chronic mild stress model of depression Physiol Behav 78 2003 703 710
85. A.J. Grippo, J. Francis, R.M. Weiss, R.B. Felder, A.K. Johnson Cytokine mediation of experimental heart failure-induced anhedonia Am J Physiol Regul Integr Comp 284 2003 R666 R673
86. R. Gross-Isseroff, A. Biegon, H. Voet, A. Weizman The suicide brain a review of postmortem receptor/transporter binding studies Neurosci Biobehav Rev 22 1998 653 661
87. R. Grossman, M.S. Buchsbaum, R. Yehuda Neuroimaging studies in post-traumatic stress disorder Psychiatr Clin North Am 25 2002 317 340
88. O. Guillin, J. Diaz, P. Carroll, N. Griffon, J.C. Schwartz, P. Sokoloff BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization Nature 411 2001 86 89
89. U.K. Hanisch Microglia as a source and target of cytokines Glia 40 2002 140 155
90. P.J. Harrison The neuropathology of primary mood disorder Brain 125 2002 1428 1449
91. K. Hashimoto, E. Shimizu, M. Iyo Critical role of brain-derived neurotrophic factor in mood disorders Brain Res Rev 45 2004 104 114
92. P. Hauser, J. Khosla, H. Aurora, J. Laurin, M.A. Kling, J. Hill, M. Gulati, A.J. Thornton, R.L. Schultz, A.D. Valentine, C.A. Meyers, C.D. Howell A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with Hepatitis C Mol Psychiatry 7 2002 942 947
93. S. Hayley, K. Brebner, S. Lacosta, Z. Merali, H. Anisman Sensitization to the effects of tumor necrosis factor-a neuroendocrine, central monoamine and behavioral variations J Neurosci 19 1999 5654 5665
94. S. Hayley, O. Kelly, H. Anisman Murine tumor necrosis factor α sensitizes plasma corticosoterone and manifestation of shock Modulation by histamine J Neuroimmunol 131 2003 60 69
95. S. Hayley, W.M. Staines, Z. Merali, H. Anisman Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha Neuroscience 106 2001 137 148
96. S. Hayley, P. Wall, H. Anisman Sensitization to the neuroendocrine, central monoamine and behavioral effects of murine tumor necrosis factor-α peripheral and central mechanisms Eur J Neurosci 15 2002 1061 1076
97. S. Hayley, H. Anisman Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states neurochemical and molecular substrates Curr Pharm Design 2004 in press.
98. S. Hayley, S.J. Crocker, P.D. Smith, T. Shree, V. Jackson-Lewis, S. Przedborski, M. Mount, R. Slack, H. Anisman, D.S. Park Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease J Neurosci 24 2004 2045 2053
99. J. Hellsten, M. Wennstrom, P. Mohapel, C.T. Ekdahl, J. Bengzon, A. Tingstrom Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment Eur J Neurosci 16 2002 283 290
100. J.P. Herman, W.E. Cullinan Neurocircuitry of stress Central control of hypothalamo-pituitary-adrenocortical axis Trends Neurosci 20 1997 78 84
101. I. Heuser, G. Bissette, M. Dettling, U. Schweiger, U. Gotthardt, J. Schmider, C.H. Lammers, C.B. Nemeroff, F. Holsboer Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls response to amitriptyline treatment Depress Anxiety 8 1998 71 79
102. C. Hock, K. Heese, F. Muller-Spahn, P. Huber, W. Riesen, R.M. Nitsch, U. Otten Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression Mol Psychiatry 5 2000 510 513
103. F. Holsboer Corticotropin-releasing hormone modulators and depression Curr Opin Investig Drugs 4 2003 46 50
104. A. Honig, J.R. Bartlett, N. Bouras, P.K. Bridges Amino acid levels in depression a preliminary investigation J Psychiatr Res 22 1988 159 164
105. D. Hucks, S. Lowther, M.R. Crompton, C.L. Katona, R.W. Horton Corticotropin-releasing factor binding sites in cortex of depressed suicides Psychopharmacology 199 1997 174 178
106. P.A. Iredale, R. Terwilliger, K.L. Widnell, E.J. Nestler, R.S. Duman Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells Mol Pharmacol 50 1996 1103 1110
107. M. Irwin Immune correlates of depression Adv Exp Med Biol 461 1999 1 24
108. B.L. Jacobs Adult brain neurogenesis and depression Brain Behav Immun 16 2002 602 609
109. J.D. Johnson, K.A. O'Connor, L.R. Watkins, S.F. Maier The role of IL-1β in stress-induced sensitization of proinflammatory cytokine and corticosterone responses Neuroscience 127 2004 569 577
110. P.W. Kalivas, M. Nakamura Neural systems for behavioral activation and reward Curr Opin Neurobiol 9 1999 223 227
111. H. Kamikawa, T. Hori, H. Nakane, S. Aou, N. Tashiro IL-1beta increases norepinephrine level in rat frontal cortex involvement of prostanoids, NO, and glutamate Am J Physiol 275 1998 R803 R810
112. M.B. Keller Long-term treatment strategies in affective disorders Psychopharmacol Bull 36 2002 36 48
113. G. Kempermann, G. Kronenberg Depressed new neurons adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression Biol Psychiatry 54 2003 499 503
114. W. Kern, W. Sieghart Polyclonal antibodies directed against an epitope specific for the alpha 4-subunit of GABAA receptors identify a 67-kDa protein in rat brain membranes J Neurochem 62 1994 764 769
115. M.A. Kling, A. Roy, A.R. Doran, J.R. Calabrese, D.R. Rubinow, H.J. Whitfield, C. May, R.M. Post, G.P. Chrousos, P.W. Gold Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression potential clinical implications J Clin Endocrinol Metab 72 1991 260 271
116. J.M. Koch, S. Kell, D. Hinze-Selch, J.B. Aldenhoff Changes in CREB-phosphorylation during recovery from major depression J Psychiatr Res 36 2002 369 375
117. E.R. Korpi, J.E. Kleinman, R.J. Wyatt GABA concentrations in forebrain areas of suicide victims Biol Psychiatry 23 1988 109 114
118. M.R. Kraus, A. Schafer, H. Faller, H. Csef, M. Scheurlen Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C Aliment Pharmacol Ther 16 2002 1091 1099
119. J.H. Krystal, G. Sanacora, H. Blumberg, A. Anand, D.S. Charney, G. Marek, C.N. Epperson, A. Goddard, G.F. Mason Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments Mol Psychiatry 7 2002 S71 S80
120. I.C. Lai, C.J. Hong, S.J. Tsai Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment Neuropsychobiology 48 2003 182 185
121. S.J. Larson, R.L. Romanoff, A.J. Dunn, J.R. Glowa Effects of interleukin-1beta on food-maintained behavior in the mouse Brain Behav Immun 16 2002 398 410
122. A. Leake, E.K. Perry, R.H. Perry, A.F. Fairbairn, I.N. Ferrier Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression Biol Psychiatry 28 1990 603 608
123. S. Lemonde, G. Turecki, D. Bakish, L. Du, P.D. Hrdina, C.D. Bown, A. Sequeira, N. Kushwaha, S.J. Morris, A. Basak, X.M. Ou, P.R. Albert Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide J Neurosci 23 2003 8788 8799
124. A.C.E. Linthorst, C. Flachskamm, P. Muller-Preuss, F. Holsboer, J.M.H.M. Reul Effect of bacterial endotoxin and interleukin-1b on hippocampal serotonergic neurotransmision, behavioral activity, and free corticosterone levels An in vivo microdialysis study J Neurosci 15 1995 2920 2934
125. D. Liu, J. Diorio, J.C. Day, D.D. Francis, M.J. Meaney Maternal care, hippocampal synaptogenesis and cognitive development in rats Nat Neurosci 3 2000 799 806
126. S. Lowther, F. De Paermentier, S.C. Cheetham, M.R. Crompton, C.L. Katona, R.W. Horton 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls J Affect Disord 42 1997 199 207
127. P.J. Lucassen, M.B. Muller, F. Holsboer, J. Bauer, A. Holtrop, J. Wouda, W.J. Hoogendijk, E.R. De Kloet, D.F. Swaab Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure Am J Pathol 158 2001 453 468
128. X.C. Ma, P.E. Gottschall, L.T. Chen, M. Wiranowska, C.P. Phelps Role and mechanisms of interleukin-1 in the modulation of neurotoxicity Neuroimmunomodulation 10 2002 199 207
129. F.P. MacMaster, V. Kusumakar Hippocampal volume in early onset depression BMC Med 2 2004 2
130. G.M. MacQueen, S. Campbell, B.S. McEwen, K. Macdonald, S. Amano, R.T. Joffe, C. Nahmias, L.T. Young Course of illness, hippocampal function, and hippocampal volume in major depression Proc Natl Acad Sci U S A 100 2003 1387 1392
131. M. Maes Major depression and activation of the inflammatory response system Adv Exp Med Biol 461 1999 25 46
132. M. Maes, S. Bonaccorso Lower activities of serum peptidases predict higher depressive and anxiety levels following interferon-alpha-based immunotherapy in patients with hepatitis C Acta Psychiatr Scand 109 2004 126 131
133. M. Maes, L. Capuron, A. Ravaud, N. Gualde, E. Bosmans, B. Egyed Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy Neuropsychopharmacology 24 2001 130 140
134. M. Maes, H.Y. Meltzer The serotonin hypothesis of major depression F.E. Bloom Psychopharmacology the third generation of progress 1995 Raven Press New York 993-944
135. A.M. Magarinos, B.S. McEwen, G. Flugge, E. Fuchs Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews J Neurosci 16 1996 3534 3540
136. F.O. Maher, D.S. Martin, M.A. Lynch Increased IL-1beta in cortex of aged rats is accompanied by downregulatin of ERK and PI-3 kinase Neurobiol Aging 25 6 2004 795 806
137. S.F. Maier, L.R. Watkins Cytokines for psychologists Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition Psychol Rev 105 1998 83 107
138. J.E. Malberg, R.S. Duman Cell proliferation in adult hippocampus is decreased by inescapable stress reversal by fluoxetine treatment Neuropsychopharmacology 28 2003 1562 1571
139. J.E. Malberg, A.J. Eisch, E.J. Nestler, R.S. Duman Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J Neurosci 20 2000 9104 9110
140. H.K. Manji, G. Chen PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers Mol Psychiatry 7 2002 S46 S56
141. H.K. Manji, W.C. Drevets, D.S. Charney The cellular neurobiology of depression Nat Med 7 2001 541 547
142. H.K. Manji, R.S. Duman Impairments of neuroplasticity and cellular resilience in severe mood disorders implications for the development of novel therapeutics Psychopharmacol Bull 35 2001 5 49
143. H.K. Manji, J.A. Quiroz, J. Sporn, J.L. Payne, K.A. Denicoff, N. Gray, C.A. Zarate Jr., D.S. Charney Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression Biol Psychiatry 53 2003 707 742
144. J.J. Mann, Y.Y. Huang, M.D. Underwood, S.A. Kassir, S. Oppenheim, T.M. Kelly, A.J. Dwork, V. Arango A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide Arch Gen Psychiatry 57 2000 729 738
145. F. Marmigere, L. Givalois, F. Rage, S. Arancibia, L. Tapia-Arancibia Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats Hippocampus 13 2003 646 655
146. M.P. Mattson, S. Maudsley, B. Martin BDNF and 5-HT a dynamic duo in age-related neuronal plasticity and neurodegerative disorders Trends Neurosci 27 2004 589 594
147. W.M. McDonald, I.H. Richard, M.R. DeLong Prevalence, etiology, and treatment of depression in Parkinson's disease Biol Psychiatry 54 2003 363 375
148. B.S. McEwen Plasticity of the hippocampus adaptation to chronic stress and allostatic load Ann N Y Acad Sci 933 2001 265 277
149. M.J. Meaney Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations Annu Rev Neurosci 24 2001 1161 1192
150. D.B. Menkes, J.A. MacDonald Interferons, serotonin and neurotoxicity Psychol Med 30 2000 259 268
151. Z. Merali, K. Brennan, P. Brau, H. Anisman Dissociating anorexia and anhedonia elicited by interleukin-1β antidepressant and gender effects on responding for "free chow" and "earned" sucrose intake Psychopharmacology 165 2003 413 418
152. A receptor subunits in frontal cortical brain region J Neurosci 24 2004 1478-1285
153. Z. Merali, S. Khan, D.S. Michaud, S.A. Shippy, H. Anisman Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release Eur J Neurosci 20 2004 229 239
154. Z. Merali, S. Lacosta, H. Anisman Effects of interleukin-1b and mild stress on alterations of central monoamines A regional microdialysis study Brain Res 761 1997 225 235
155. Z. Merali, J. McIntosh, P. Kent, D. Michaud, H. Anisman Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala J Neurosci 18 1998 4758 4766
156. G. Mercier, A.M. Lennon, B. Renouf, A. Dessouroux, M. Ramauge, F. Courtin, M. Pierre MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes J Mol Neurosci 24 2004 207 216
157. P.E. Merlo, M. Lorang, M. Yeganeh, D.F. Rodriguez, J. Raber, G.F. Koob, F. Weiss Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis J Neurosci 15 1995 5439 5447
158. S. Mertens, D. Benke, H. Mohler GABAA receptor populations with novel subunit combinations and drug binding profiles identified in brain by alpha 5- and delta-subunit-specific immunopurification J Biol Chem 268 1993 5965 5973
159. E. Mervaala, J. Fohr, M. Kononen, M. Valkonen-Korhonen, P. Vainio, K. Partanen, J. Partanen, J. Tiihonen, H. Viinamaki, A.K. Karjalainen, J. Lehtonen Quantitative MRI of the hippocampus and amygdala in severe depression Psychol Med 30 2000 117 125
160. J.H. Meyer, S. Kapur, S. Houle, J. DaSilva, B. Owczarek, G.M. Brown, A.A. Wilson, S.H. Kennedy Prefrontal cortex 5-HT2 receptors in depression an [18F]setoperone PET imaging study Am J Psychiatry 156 1999 1029 1034
161. C.A. Meyers, A.D. Valentine Neurological and psychiatric adverse effects of immunological therapy CNS Drugs 3 1995 56 68
162. A.M. Minogue, A.W. Schmid, M.P. Fogarty, A.C. Moore, V.A. Campbell, C.E. Herron, M.A. Lynch Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus a role for interleukin-1beta J Biol Chem 278 30 2003 27971 27980
163. S. Miyahara, T. Komori, R. Fujiwara, K. Shizuya, M. Yamamoto, M. Ohmori, Y. Okazaki Effects of repeated stress on expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat hypothalamus and midbrain Life Sci 66 2000 PL93 PL98
164. H. Miyaoka, T. Otsubo, K. Kamijima, M. Ishii, M. Onuki, K. Mitamura Depression from interferon therapy in patients with hepatitis C Am J Psychiatry 156 1999 1120
165. B. Moghaddam, M.L. Bolinao, B. Stein-Behrens, R. Sapolsky Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate Brain Res 655 1994 251 254
166. N. Mullar, M. Ackenheil Psychoneuroimmunology and the cytokine action in the CNS implications for psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 22 1998 1 33
167. P.G. Murphy, L.A. Borthwick, M. Altares, J. Gauldie, D. Kaplan, P.M.
168. D.L. Musselman, D.H. Lawson, J.F. Gumnick, A.K. Manatunga, S. Penna, R.S. Goodkin, K. Greiner, C.B. Nemeroff, A.H. Miller Paroxetine for the prevention of depression induced by high-dose interferon alfa N Engl J Med 344 2001 961 966
169. T. Nagatsu, M. Mogi, H. Ichinose, A. Togari Changes in cytokines and neurotrophins in Parkinson's disease J Neural Transm Suppl 60 2000 277 290
170. L. Nassberger, L. Traskman-Bendz Increased soluble interleukin-2 receptor concentrations in suicide attempters Acta Psychiatr Scand 88 1993 48 52
171. C.B. Nemeroff The corticotropin-releasing factor (CRF) hypothesis of depression New findings and new directions Mol Psychiatry 1 1996 336 342
172. C.B. Nemeroff, G. Bissette, H. Akil, M. Fink Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin Br J Psychiatry 158 1991 59 63
173. C.B. Nemeroff, M.J. Owens, G. Bissette, A.C. Andorn, M. Stanley Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims Arch Gen Psychiatry 45 1988 577 579
174. C.B. Nemeroff, E. Widerlov, G. Bissette, H. Walleus, I. Karlsson, K. Eklund, C.D. Kilts, P.T. Loosen, W. Vale Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients Science 226 1984 1342 1344
175. K.T. Nguyen, T. Deak, S.M. Owens, T. Kohno, M. Fleshner, L.R. Watkins, S.F. Maier Exposure to acute stress induces brain interleukin-1β protein in the rat J Neurosci 19 1998 2799 2805
176. P.V. Nguyen, N.H. Woo Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases Prog Neurobiol 71 2003 401 437
177. Y. Obara, N. Nakahata The signaling pathway of neurotrophic factor biosynthesis Drug News Perspect 15 2002 290 298
178. Y. Odagaki, J.A. Garcia-Sevilla, P. Huguelet, R. La Harpe, T. Koyama, J. Guimon Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims Brain Res 898 2001 224 231
179. G.N. Pandey, Y. Dwivedi, H.S. Rizavi, X. Ren, S.C. Pandey, C. Pesold, R.C. Roberts, R.R. Conley, C.A. Tamminga Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims Am J Psychiatry 159 2002 419 429
180. S. Pawate, Q. Shen, F. Fan, N.R. Bhat Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma J Neurosci Res 77 2004 540 551
181. F. Petty GABA and mood disorders a brief review and hypothesis J Affect Disord 34 1995 275 281
182. C.S. Piao, J.B. Kim, P.L. Han, J.K. Lee Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult J Neurosci Res 73 4 2003 537 544
183. R.C. Pierce, A.F. Pierce-Bancroft, B.M. Prasad Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade J Neurosci 19 1999 8685 8695
184. A.F. Pitts, S.D. Samuelson, W.H. Meller, G. Bissette, C.B. Nemeroff, R.G. Kathol Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls Biol Psychiatry 38 1995 330 335
185. J.M. Pocock, A.C. Liddle Microglial signalling cascades in neurodegenerative disease Prog Brain Res 132 2001 555 565
186. G. Pozzoli, L.M. Bilezikjian, M.H. Perrin, A.L. Blount, W.W. Vale Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures Endocrinology 137 1996 65 71
187. D.C. Purselle, C.B. Nemeroff Serotonin transporter a potential substrate in the biology of suicide Neuropsychopharmacology 28 2003 613 619
188. F.C. Raadsheer, W.J. Hoogendijk, F.C. Stam, F.J. Tilders, D.F. Swaab Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients Neuroendocrinology 60 1994 436 444
189. F.C. Raadsheer, J.J. van Heerikhuize, P.J. Lucassen, W.J. Hoogendijk, F.J. Tilders, D.F. Swaab Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression Am J Psychiatry 152 1995 1372 1376
190. F. Rage, L. Givalois, F. Marmigere, L. Tapia-Arancibia, S. Arancibia Immobilization stress rapidly modulates BDNF mRNA expression in the hypothalamus of adult male rats Neuroscience 112 2002 309 318
191. G. Rajkowska Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells Biol Psychiatry 48 2000 766 777
192. A.M. Rasmusson, L. Shi, R. Duman Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock Neuropsychopharmacology 27 2002 133 142
193. M. Rattazzi, M. Puato, E. Faggin, B. Bertipaglia, A. Zambon, P. Pauletto C-reactive protein and interleukin-6 in vascular disease culprits or passive bystanders? J Hypertens 21 2003 1787 1803
194. D.S. Reddy Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol Sci 24 2003 103 106
195. J.M. Reul, F. Holsboer Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression Curr Opin Pharmacol 2 2002 23 33
196. S.K. Roach, S.B. Lee, J.S. Schorey Differential activation of the transcription factor cyclic AMP response element binding protein (CREB) in macrophages following infection with pathogenic and nonpathogenic mycobacteria and role for CREB in tumor necrosis factor alpha production Infect Immun 73 2005 514 522
197. J. Roth, E.M. Harre, C. Rummel, R. Gerstberger, T. Hubschle Signaling the brain in systemic inflammation role of sensory circumventricular organs Front Biosci 9 2004 290 300
198. M. Rothermundt, V. Arolt, M. Peters, H. Gutbrodt, J. Fenker, A. Kersting Inflammatory markers in major depression and melancholia J Affect Disord 63 2001 93 102
199. N.J. Rothwell Annual review prize lecture cytokines killers in the brain? J Physiol 514 1999 3 17
200. A. Roy, D. Pickar, S. Paul, A. Doran, G.P. Chrousos, P.W. Gold CSF corticotropin-releasing hormone in depressed patients and normal control subjects Am J Psychiatry 144 1987 641 645
201. P. Roy-Byrne, D.K. Wingerson, A. Radant, D.J. Greenblatt, D.S. Cowley Reduced benzodiazepine sensitivity in patients with panic disorder comparison with patients with obsessive-compulsive disorder and normal subjects Am J Psychiatry 153 1996 1444 1449
202. D.A. Ruggiero, M.D. Underwood, P.M. Rice, J.J. Mann, V. Arango Corticotropic-releasing hormone and serotonin interact in the human brainstem behavioral implications Neuroscience 91 1999 1343 1354
203. R.M. Sapolsky The possibility of neurotoxicity in the hippocampus in major depression a primer on neuron death Biol Psychiatry 48 2000 755 765
204. R.M. Sapolsky, L.C. Krey, B.S. McEwen Prolonged glucocorticoid exposure reduces hippocampal neuron number implications for aging J Neurosci 5 1985 1222 1227
205. R.M. Sapolsky, H. Uno, C.S. Rebert, C.E. Finch Hippocampal damage associated with prolonged glucocorticoid exposure in primates J Neurosci 10 1990 2897 2902
206. M.S. Saporito, R.L. Hudkins, A.C. Maroney Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases Prog Med Chem 40 2002 23 62
207. A.F. Schatzberg, J.J. Schildkraut Recent studies on norepinephrine systems on mood disorders F.E. Bloom D.J. Kupfer Psychopharmacology the fourth generation of progress 1995 Raven New York 911 922
208. S. Schlegel, H. Steinert, A. Bockisch, K. Hahn, R. Schloesser, O. Benkert Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report Eur Arch Psychiatry Clin Neurosci 244 1994 49 51
209. E.D. Schmidt, R. Binnekade, A.W. Janszen, F.J. Tilders Short stressor induced long-lasting increases of vasopressin stores in hypothalamic corticotropin-releasing hormone (CRH) neurons in adult rats J Neuroendocrinol 8 1996 703 712
210. T.M. Schramm, B.R. Lawford, G.A. Macdonald, W.G. Cooksley Sertraline treatment of interferon-alfa-induced depressive disorder Med J Aust 173 2000 359 361
211. N. Shanks, R.J. Windle, P.A. Perks, M.S. Harbuz, D.S. Jessop, C.D. Ingram, S.L. Lightman Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation Proc Natl Acad Sci U S A 97 2000 645 650
212. K.N. Shaw, S. Commins, S.M. O'Mara Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus Behav Brain Res 124 2001 47 54
213. Y.I. Sheline, M.H. Gado, H.C. Kraemer Untreated depression and hippocampal volume loss Am J Psychiatry 160 2003 1516 1518
214. C.P. Shen, Y. Tsimberg, C. Salvadore, E. Meller Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions BMC Neurosci 20 2004 5 36
215. F. Sherif, J. Marcusson, L. Oreland Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims Eur Arch Psychiatry Clin Neurosci 241 1991 139 144
216. I.S. Shiah, L.N. Yatham GABA function in mood disorders an update and critical review Life Sci 63 1998 1289 1303
217. E. Shimizu, K. Hashimoto, N. Okamura, K. Koike, N. Komatsu, C. Kumakiri, M. Nakazato, H. Watanabe, N. Shinoda, S. Okada, M. Iyo Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants Biol Psychiatry 54 2003 70 75
218. F. Shintani, S. Kanba, T. Nakaki, M. Nibuya, N. Kinoshita, E. Suzuki, G. Yagi, R. Kato, M. Asai Interleukin-1β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus J Neurosci 13 1993 3574 3581
219. F. Shintani, T. Nakaki, S. Kanba, K. Sato, G. Yagi, M. Shiozawa, S. Aiso, R. Kato, M. Asai Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat J Neurosci 15 1995 1961 1970
220. Y. Shirayama, A.C. Chen, S. Nakagawa, D.S. Russell, R.S. Duman Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J Neurosci 22 2002 3251 3261
221. E. Sibille, C. Pavlides, D. Benke, M. Toth Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety J Neurosci 20 2000 2758 2765
222. E. Sibille, V. Arango, H.C. Galfalvy, P. Pavlidis, L. Erraji-Benchekroun, S.P. Ellis, Mann John Gene expression profiling of depression and suicide in human prefrontal cortex Neuropsychopharmacology 29 2004 351 361
223. F.S. Silverstein, J.D. Barks, P. Hagan, X.H. Liu, J. Ivacko, J. Szaflarski Cytokines and perinatal brain injury Neurochem Int 30 1997 375 383
224. A. Sluzewska Indicators of immune activation in depressed patients Adv Exp Med Biol 461 1999 59 74
225. M.A. Smith, S. Makino, M. Altemus, D. Michelson, S.K. Hong, R. Kvetnansky, R.M. Post Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus Proc Natl Acad Sci 92 19 1995 8788 8792
226. R.S. Smith The macrophage theory of depression Med Hypotheses 35 1991 298 306
227. P. Sokoloff, O. Guillin, J. Diaz, P. Carroll, N. Griffon Brain-derived neurotrophic factor controls dopamine D3 receptor expression implications for neurodevelopmental psychiatric disorders Neurotox Res 4 2002 671 678
228. C. Song, Z. Merali, H. Anisman Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment Neuroscience 88 1999 823 836
229. J.L. Steiger, S.J. Russek GABAA receptors building the bridge between subunit mRNAs, their promoters, and cognate transcription factors Pharmacol Ther 101 2004 259 281
230. B. Stein-Behrens, M.P. Mattson, I. Chang, M. Yeh, R. Sapolsky Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus J Neurosci 14 1994 5373 5380
231. M.Y. Stepanichev, I.M. Zdobnova, A.A. Yakovlev, M.V. Onufriev, N.A. Lazareva, I.I. Zarubenko, N.V. Gulyaeva Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35) J Neurosci Res 71 2003 110 120
232. C.W. Stevenson, R.M. Sullivan, A. Gratton Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortical dopamine responses to stress Neuroscience 116 2003 285 293
233. C.A. Stockmeier Involvement of serotonin in depression evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter J Psychiat Res 37 2003 357 373
234. C.A. Stockmeier, G.E. Dilley, L.A. Shapiro, J.C. Overholser, P.A. Thompson, H.Y. Meltzer Serotonin receptors in suicide victims with major depression Neuropsychopharmacology 16 1997 162 173
235. G. Stoll, S. Jander, M. Schroeter Cytokines in CNS disorders neurotoxicity versus neuroprotection J Neural Transm 59 2000 81 89
236. S.C. Stout, M.J. Owens, K.P. Lindsey, D.L. Knight, C.B. Nemeroff Effects of sodium valproate on corticotropin-releasing factor systems in rat brain Neuropsychopharmacology 24 2001 624 631
237. I. Sundman-Eriksson, P. Allard [(3)H]Tiagabine binding to GABA transporter-1 (GAT-1) in suicidal depression J Affect Disord 71 2002 29 33
238. I. Sundman, P. Allard, A. Eriksson, J. Marcusson GABA uptake sites in frontal cortex from suicide victims and in aging Neuropsychobiology 35 1997 11 15
239. H. Tan, P. Zhong, Z. Yan Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons J Neurosci 24 2004 5000 5008
240. J. Tanji, E. Hoshi Behavioral planning in the prefrontal cortex Curr Opin Neurobiol 11 2001 164 170
241. F.J.H. Tilders, E.D. Schmidt, D.C.E. De Goeij Phenotypic plasticity of CRF neurons during stress Ann N Y Acad Sci 697 1993 39 52
242. F.J.H. Tilders, E.D. Schmidt Cross-sensitization between immune and non-immune stressors. A role in the etiology of depression? Adv Exp Med Biol 461 1999 179 197
243. G. Tunnicliff, E. Malatynska Central GABAergic systems and depressive illness Neurochem Res 28 2003 965 976
244. H. Uno, S. Eisele, A. Sakai, S. Shelton, E. Baker, O. DeJesus, J. Holden Neurotoxicity of glucocorticoids in the primate brain Horm Behav 28 1994 336 348
245. K. Vakili, S.S. Pillay, B. Lafer, M. Fava, P.F. Renshaw, C.M. Bonello-Cintron, D.A. Yurgelun-Todd Hippocampal volume in primary unipolar major depression a magnetic resonance imaging study Biol Psychiatry 47 2000 1087 1090
246. A.D. Valentine, C.A. Meyers, M. Talpaz Treatment of neurotoxic side effects of interferon-alpha with naltrexone Cancer Invest 13 1995 561 566
247. E.E. Varfolomeev, A. Ashkenazi Tumor necrosis factor an apoptosis JuNKie? Cell 116 2004 491 497
248. A. Vezzani, D. Moneta, C. Richichi, M. Aliprandi, S.J. Burrows, T. Ravizza, C. Perego, M.G. De Simoni Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis Epilepsia 43 2002 30 35
249. M. Vythilingam, E. Vermetten, G.M. Anderson, D. Luckenbaugh, E.R. Anderson, J. Snow, L.H. Staib, D.S. Charney, J.D. Bremner Hippocampal volume, memory, and cortisol status in major depressive disorder effects of treatment Biol Psychiatry 56 2004 101 112
250. D.L. Walker, M. Davis Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear J Neurosci 17 1997 9375 9383
251. T.L. Wallace, K.E. Stellitano, R.L. Neve, R.S. Duman Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety Biol Psychiatry 56 2004 151 160
252. C.X. Wang, A. Shuaib Involvement of inflammatory cytokines in central nervous system injury Prog Neurobiol 67 2002 161 172
253. Q. Wang, D.M. Walsh, M.J. Rowan, D.J. Selkoe, R. Anwyl Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5 J Neurosci 24 13 2004 3370 3378
254. M. Wichers, M. Maes The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans Int J Neuropsychopharmacol 5 2002 375 388
255. M.C. Wichers, M. Maes The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression J Psychiatry Neurosci 29 2004 11 17
256. R.A. Wise Dopamine, learning and motivation Nat Rev Neurosci 5 2004 483 494
257. M.L. Wong, M.A. Kling, P.J. Munson, S. Listwak, J. Licinio, P. Prolo, B. Karp, I.E. McCutcheon, T.D. Geracioti Jr, M.D. DeBellis, K.C. Rice, D.S. Goldstein, J.D. Veldhuis, G.P. Chrousos, E.H. Oldfield, S.M. McCann, P.W. Gold Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features relation to hypercortisolism and corticotropin- releasing hormone Proc Natl Acad Sci U S A 97 2000 325 330
258. A.S. Wrynn, J.B. Sebens, T. Koch, B.E. Leonard, J. Korf Prolonged c-Jun expression in the basolateral amygdala following bulbectomy possible implications for antidepressant activity and time of onset Brain Res Mol Brain Res 76 1 2000 7 17
259. S. Yamada, M. Yamamoto, H. Ozawa, P. Riederer, T. Saito Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder J Neural Transm 110 6 2003 671 680
260. Z. Yan, J. Flores-Hernandez, D.J. Surmeier Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons Neuroscience 103 2001 1017 1024
261. R. Yehuda Post-traumatic stress disorder N Engl J Med 346 2 2002 108 114
262. S.W. Ying, M. Futter, K. Rosenblum, M.J. Webber, S.P. Hunt, T.V. Bliss, C.R. Bramham Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus requirement for ERK activation coupled to CREB and upregulation of Arc synthesis J Neurosci 22 2002 1532 1540
263. R. Yirmiya, J. Weidenfeld, Y. Pollak, M. Morag, A. Morag, R. Avitsur, O. Barak, A. Reichenberg, E. Cohen, Y. Shavit, H. Ovadia Cytokines, "depression due to a general medical condition," and antidepressant drugs Adv Exp Med Biol 461 1999 283 316
264. R. Zanardi, F. Artigas, R. Moresco, C. Colombo, C. Messa, C. Gobbo, E. Smeraldi, F. Fazio Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment a positron emission tomography scan study J Clin Psychopharmacol 21 2001 53 58
265. D. Zhang, K. Kishihara, B. Wang, K. Mizobe, C. Kubo, K. Nomoto Restraint stress-induced immunosuppression by inhibiting leukocyte migration and Th1 cytokine expression during the intraperitoneal infection of Listeria monocytogenes J Neuroimmunol 92 1998 139 151
266. T. Ziemssen, T. Kumpfel, W.E. Klinkert, O. Neuhaus, R. Hohlfeld Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor Brain 125 2002 2381 2391